Is narcolepsy an autoimmune disorder which should be treated as such?
Capsule: Narcolepsy is a relatively rare disorder and its cause is unknown. There is a genetic component, particularly the HLA system, which is important in immune regulation. This leads to the hypothesis that interference with the immune system may be helpful in patents.
17:00-17:20
Yes:Jacek Losy, Poland
17:20-17:40
No:Angela Vincent, UK
17:40-17:50
Discussion and rebuttals
17:50-18:40
Treatment of CIDP – immunoglobulins or steroids first?
Capsule: Many treatments have been advocated for CIDP, but the best accepted options are intravenous immunoglobulins and corticosteroids. Which treatment is best and should be applied first?
17:50-18:10
Immunoglobulins: Helmar Lehmann, Germany
18:10-18:30
Steroids: Joab Chapman, Israel
18:30-18:40
Discussion and rebuttals
18:40-19:30
PANDAS (PANS/CANS) is a clinically distinct entity and needs early and prompt immunotherapy.
Capsule: The nosology of pediatric acute neuropsychiatric syndromes like PANDAS remains controversial, and the evidence for immunopathology and in particular autoimmunity driven by streptococcal infection is still being questioned. Is PANDAS a distinct disorder and is prompt immunotherapy indicated for treatment?
